Stroke prophylaxis in patients with atrial fibrillation: what can we do about it?
Naunton
Mark
M
D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications*; D006801:Humans; D012307:Risk Factors; D020521:Stroke / Q000517:prevention & control*; D013648:Tasmania; D014859:Warfarin / Q000627:therapeutic use*
D000925:Anticoagulants; D014859:Warfarin